Perimenopausal Insomnia: Why CBT-I Still Works When Hormonal Change Is the Trigger

Last reviewed: 08/25/2026

Reviewed by: Dr. Kiesa Kelly

There is a reasonable-sounding objection that stops a lot of women from trying the treatment most likely to help them: a hot flash wakes me up, so how is a talking therapy supposed to fix that?

It is a fair question, and it has a specific answer. The thing that wakes you and the thing that keeps you awake are not the same thing — and only one of them is what insomnia treatment targets.

In this article, you'll learn:

• Why a hormonal trigger does not make this a different kind of insomnia

• How a vasomotor wake turns into a maintained sleep problem

• What the evidence actually shows in perimenopausal women specifically

• Why sleep hygiene is the component that underperforms

• What is honest to say about durability, and what is still unknown

Why hormonal insomnia is still insomnia — the one-paragraph answer

Insomnia is diagnosed and treated by its maintaining mechanism, not by its trigger. Something starts a period of disrupted sleep — in perimenopause, most often a night-time hot flash — and then a second set of processes decides whether it becomes a chronic problem: lying awake watching the clock, going to bed earlier to catch up, spending nine hours in bed to get six hours of sleep, and the learned association between the bed and being wide awake. Those maintaining processes are the same regardless of what set them off, which is why the first-line treatment is the same too. Cognitive behavioural therapy for insomnia is recommended as first-line for chronic insomnia in adults by the American Academy of Sleep Medicine [1] and by the current European guideline, which specifies it applies with or without co-morbidities [2].

🌙 Key takeaway: The hot flash is the trigger. The insomnia is what your sleep system does afterwards — and that is the treatable part.

What perimenopausal insomnia actually looks like

Sleep difficulty is extremely common in this transition. A large community survey of women at midlife found that around 38% reported difficulty sleeping [3]. A smaller share — roughly a quarter of women — experience symptoms severe enough to meet criteria for insomnia and to impair daytime functioning [4]. Those two figures measure different things and are worth keeping apart: one is a symptom, the other is a disorder.

Consider a woman at 51 who used to sleep straight through. Now she wakes around 2am, damp and too hot, throws off the duvet, and is fully alert within seconds. She waits. Twenty minutes becomes fifty. She starts calculating how much sleep is still available if she falls asleep right now, and the calculation itself is activating. By 3:30 she is awake enough to check email. She has begun going to bed at 9:30 to build in a buffer, which means she now spends nine and a half hours in bed for about six hours of sleep, and most of the extra time is spent awake and frustrated.

Or consider someone whose flashes are actually fairly mild. She wakes once, briefly, and could probably drift back — except that she has started dreading the wake-up, so she goes to bed already braced for it. The bracing is the problem. Some nights she has no flash at all and still lies awake for an hour, waiting for one.

Vasomotor wakes vs sleep-maintenance insomnia

The distinction that matters clinically is between the awakening and the inability to return to sleep. A vasomotor event can rouse you; that is a physiological fact and behavioural treatment does not claim to prevent it. What determines whether you get four more hours or forty more minutes is what happens in the next ten minutes — and that is largely learned, largely behavioural, and highly modifiable.

This is also where three common beliefs get in the way.

"If the cause is hormonal, the fix must be hormonal." In reality, cause and maintenance come apart in almost every chronic condition. The evidence below shows sleep improving substantially in women whose hot flashes did not decrease at all.

"I just need better sleep hygiene." In reality, sleep hygiene alone is the weakest component of the toolkit, and current guidance specifically advises against using it as a standalone therapy [1]. It is the part everyone has already tried, which is part of why so many women conclude nothing works.

"More time in bed will help me catch up." In reality, extending time in bed is one of the most reliable ways to make chronic insomnia worse. It dilutes sleep across a longer window and strengthens the association between the bed and wakefulness.

How a hormonal trigger becomes a learned pattern

The standard explanation is the hyperarousal model: chronic insomnia is characterised by elevated arousal across autonomic, neuroendocrine and cortical measures, and that arousal is both a vulnerability and a consequence [5]. Layered onto it is a conditioning account — the bed becomes a cue for wakefulness rather than sleep.

It is worth being precise about the evidence status here. Hyperarousal in insomnia disorder is well supported [5]. The specific claim that a vasomotor wake becomes a conditioned arousal in perimenopausal women is a reasonable extension of an established model, not something a study has demonstrated directly. Treat it as a working framework — a useful one, since it is what the treatment acts on.

🔁 Key takeaway: What turns a bad month into a chronic problem is usually the coping: earlier bedtimes, longer lie-ins, more time awake in bed.

What CBT-I does that sleep hygiene doesn't

CBT-I is a multi-component treatment, and we have covered what CBT-I includes in detail elsewhere — this section is about which parts do the work in this specific situation.

Sleep restriction and stimulus control, briefly

The two components that carry most of the effect are the two that sound least appealing. Sleep restriction temporarily compresses your time in bed to match the sleep you are actually getting, which increases sleep pressure and consolidates fragmented sleep. Stimulus control rebuilds the bed-equals-sleep association by getting you out of bed when you are awake for long.

Both are uncomfortable for the first week or two, and both are frequently abandoned by people attempting them without support. That is precisely the difference between CBT-I and sleep hygiene advice: one asks you to do something difficult that works, the other asks you to do something easy that mostly does not.

Targeting the arousal that follows the hot flash

Here is the mechanism-level answer to the objection this article opened with. CBT-I does not attempt to reduce hot flashes. It targets the ninety minutes after one — the clock-watching, the arithmetic about tomorrow, the frustration, and the decision to stay in bed hoping. Those are exactly the maintaining factors the treatment was built for, and they are indifferent to whether the initial wake came from a hot flash, a noise, or a full bladder.

🎯 Key takeaway: The treatment does not try to stop the flash. It targets the ninety minutes afterwards, which is where the sleep is actually lost.

What the evidence says in perimenopause specifically

This is not extrapolation from general insomnia populations. The trials were done in these women.

The most directly relevant is a randomized trial of telephone-delivered CBT-I in perimenopausal and postmenopausal women who all had insomnia and at least two hot flashes a day. Insomnia severity fell by 9.9 points in the CBT-I group versus 4.7 in the control condition, a between-group difference of 5.2 points, with sleep-quality gains of the same shape and group differences sustained at 24 weeks [6]. By six months, 84% of the CBT-I group scored in the no-insomnia range, against 43% of controls [6].

The finding that answers the objection: there was no between-group difference in how many hot flashes women had. What changed was how much the flashes interfered [6]. Sleep improved without the trigger going away.

A pooled analysis of individual participant data from four trials in 546 women with hot flashes compared several interventions head to head. CBT-I produced the largest reduction in insomnia severity at 5.2 points; exercise and venlafaxine produced roughly 2.1 and 2.3 points; escitalopram, yoga and estradiol produced comparably small changes; omega-3 supplements did not help [7]. The authors concluded the findings support CBT-I as first-line in midlife women with insomnia and bothersome vasomotor symptoms [7].

One caveat has to travel with that comparison, and it matters: the estradiol arm used low-dose oral estradiol over 8 to 12 weeks in women who were not selected for insomnia as the primary indication. That is not a fair test of standard-dose hormone therapy prescribed for sleep, and this article is not claiming CBT-I outperforms hormone therapy in general.

A separate trial in 150 postmenopausal women compared CBT-I, sleep restriction alone, and sleep hygiene education. Insomnia severity fell 7.7 points with CBT-I, 6.6 with sleep restriction, and 1.1 with sleep hygiene, and CBT-I participants gained 40 to 43 more minutes of sleep per night than either comparison [8].

CBT-I and HRT — why it isn't either/or

Nothing in the evidence above frames this as a choice between two options. Hormone therapy addresses vasomotor symptoms; CBT-I addresses the maintaining mechanism of the insomnia. A woman can reasonably want both, and whether hormone therapy is appropriate for her is a medical decision for a prescribing clinician who knows her history. This article makes no recommendation about hormone therapy, and a behavioural sleep treatment is not a substitute for medical evaluation of perimenopausal symptoms.

A trial designed to compare hormone therapy and CBT-I directly in perimenopausal women with vasomotor symptoms and insomnia is underway [9], and a Cochrane review of cognitive behavioural therapies for insomnia across the menopause transition is in progress [10]. Both are protocols. Neither has reported results, and neither should be cited as though it has.

📊 Key takeaway: In the trial where every participant had daily hot flashes, insomnia improved substantially while hot flash frequency did not change at all.

What to be cautious of: durability and honest limits

The durability picture is good but not uniform, and it is worth stating in both directions.

On the encouraging side, the telephone-CBT-I trial's group differences held at 24 weeks, with the proportion in the no-insomnia range rising between 8 and 24 weeks [6]. In the postmenopausal three-arm trial, remission rates at six-month follow-up were higher than at the end of treatment [8].

On the other side, a small 2026 pilot trial in 43 women with insomnia and nightly hot flashes tested a hybrid protocol and found the advantage over the control condition narrowed by three months — at that point it persisted for night-time sleep symptoms but no longer across the other measures [11]. It is one small pilot of a modified protocol, and it does not overturn the larger trials. It is a reason to expect that gains need maintaining rather than a reason to expect them to vanish.

Two further limits. Insomnia that persists despite good treatment, or that comes with loud snoring, witnessed breathing pauses, or profound daytime sleepiness, warrants assessment for another sleep disorder rather than more CBT-I. And low mood and anxiety commonly travel with disrupted sleep in this transition — brief measures like the PHQ-9 can help clarify whether something alongside the insomnia also needs attention.

When to get evaluated

A rule of thumb:

If your sleep has been disrupted for less than three months and is clearly tracking an obvious change, watchful waiting and avoiding the classic traps — earlier bedtimes, longer lie-ins, daytime napping — is reasonable.

If it has been three months or more, at least three nights a week, with daytime consequences, that meets the usual threshold for chronic insomnia disorder, and CBT-I is the indicated treatment regardless of what started it.

If you have tried a self-guided programme and stalled at the sleep-restriction stage, that is the most common failure point and the clearest indication for working with a clinician rather than evidence that it will not work.

If you are unsure whether this is insomnia or something else — including whether attentional or cognitive changes are part of the picture, which we cover in perimenopause, insomnia and the ADHD look-alike question — a structured psychological assessment is the efficient route.

Questions worth asking a provider before you book:

1. Do you deliver full CBT-I including sleep restriction and stimulus control, or sleep hygiene education?

2. How many sessions, and how do you handle the first two weeks when restriction feels hardest?

3. How do you work with someone whose wakes are driven by night-time hot flashes?

4. If a prescriber should be involved for the vasomotor symptoms, how does that coordination work?

🧭 Key takeaway: Three months, three nights a week, daytime consequences. That is the line where waiting stops being the better strategy.

Next step — getting support

The most common reason women in perimenopause do not get the treatment with the best evidence behind it is that they have concluded, reasonably, that a behavioural therapy cannot address a hormonal problem. The trials say otherwise, in exactly this population, including women whose hot flashes never decreased. If you have been managing 3am for months on the assumption that nothing will help until the hormones settle, that assumption is worth revisiting. Specialised therapy for insomnia is a short, structured course of treatment, not an open-ended commitment — and it works remotely, as online CBT-I delivery shows.

Sleep not coming easily?

CBT-I is the first-line, evidence-based treatment for chronic insomnia — a clinician can help you rebuild sleep without relying on medication alone.

Schedule a sleep consultation →

Frequently Asked Questions

Does CBT-I work if hot flashes are what wake me up?

Yes, and there is direct evidence for it. A randomized trial in perimenopausal and postmenopausal women who all had at least two hot flashes a day found CBT-I reduced insomnia severity roughly twice as much as the control condition, with gains sustained at six months. Notably, the number of hot flashes did not change between groups. Sleep improved without the flashes going away, which is the clearest sign that what maintains the insomnia is separable from what started it.

Should I try HRT or CBT-I first?

That is a decision for you and a prescribing clinician, and this article does not recommend either. What we can say is that CBT-I is the first-line psychological treatment for chronic insomnia in current sleep-medicine guidelines regardless of what triggered it, and that the two are not mutually exclusive. A head-to-head trial comparing them in perimenopausal women is underway but has not reported results.

Why does spending more time in bed make my sleep worse?

Because time in bed and sleep are not the same thing. Lying awake for long stretches spreads your sleep across a wider window and strengthens the association between your bed and being alert, which is one of the mechanisms that keeps chronic insomnia going. Sleep restriction, the component of CBT-I that carries much of the effect, deliberately does the opposite by temporarily shortening time in bed to consolidate sleep. It is counterintuitive, and it is uncomfortable at first.

Does telehealth CBT-I work for perimenopausal insomnia?

The trial with the strongest evidence in women with hot flashes delivered CBT-I entirely by telephone, so remote delivery is not a compromise version here. We have written about how online CBT-I works in a separate article. For a symptom that is worst at 3am and hardest to explain in a ten-minute appointment, not having to travel to an appointment is a practical advantage rather than a trade-off.

Is it too late to start CBT-I if I have had insomnia for years?

No. Chronic insomnia does not become untreatable with duration, and the menopause-specific trials enrolled women meeting full criteria for chronic insomnia disorder rather than people with a few bad weeks. What does lengthen over years of poor sleep is the set of learned associations and compensatory habits built up around it, which can make the early weeks of treatment feel harder. That is a reason to expect effort, not a reason to expect failure.

About the Author

Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare, with more than 20 years of experience in psychological assessment and evidence-based treatment. Her clinical interests include insomnia and the behavioural sleep problems that develop alongside medical and hormonal change, where the treatment target is often different from the trigger patients arrive worried about.

Dr. Kelly's background includes clinical training at the University of Chicago, Vanderbilt University, and the University of Wisconsin, and she has held academic appointments alongside her clinical practice. She reviews ScienceWorks clinical content for accuracy before publication, including this article.

References

1. Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255–262. https://doi.org/10.5664/jcsm.8986

2. Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research. 2023;32(6):e14035. https://doi.org/10.1111/jsr.14035

3. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19–28. https://pubmed.ncbi.nlm.nih.gov/12544673/

4. Baker FC, de Zambotti M, Colrain IM, Bei B. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nature and Science of Sleep. 2018;10:73–95. https://doi.org/10.2147/NSS.S125807

5. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Medicine Reviews. 2010;14(1):19–31. https://doi.org/10.1016/j.smrv.2009.04.002

6. McCurry SM, Guthrie KA, Morin CM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Internal Medicine. 2016;176(7):913–920. https://pmc.ncbi.nlm.nih.gov/articles/PMC4935624/

7. Guthrie KA, Larson JC, Ensrud KE, et al. Effects of pharmacologic and nonpharmacologic interventions on insomnia symptoms and self-reported sleep quality in women with hot flashes: a pooled analysis of individual participant data from four MsFLASH trials. Sleep. 2018;41(1):zsx190. https://pmc.ncbi.nlm.nih.gov/articles/PMC6380606/

8. Drake CL, Kalmbach DA, Arnedt JT, Cheng P, Tonnu CV, Cuamatzi-Castelan A, Fellman-Couture C. Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education. Sleep. 2019;42(2):zsy217. https://pmc.ncbi.nlm.nih.gov/articles/PMC6369725/

9. Pavicic E, Stute P, Rudzik F, Urech A, Lozza-Fiacco S. No more sleepless nights in perimenopause — study protocol for an open-label, randomized, parallel-group, active controlled intervention study of hormone replacement therapy and cognitive behavioral therapy for insomnia. Trials. 2026;27:94. https://pmc.ncbi.nlm.nih.gov/articles/PMC12860079/

10. Breitinger-Blatt D, Lee J, Ribeiro Pereira SI, Smith C, Gavriloff D, Sekaran S. Cognitive behavioural therapeutics for insomnia symptoms in the perimenopause through to the early postmenopausal period. Cochrane Database of Systematic Reviews. 2026;Protocol CD016349. https://doi.org/10.1002/14651858.CD016349

11. Arentson-Lantz EJ, Muench A, Kokonda M, Meers JM, Swartz M, Manber R, Thurston RC, Nowakowski S. Cognitive behavioral therapy for menopausal insomnia in perimenopausal and postmenopausal women with insomnia and nocturnal hot flashes: a randomized-controlled pilot trial. Menopause. 2026. https://doi.org/10.1097/GME.0000000000002779

Disclaimer

This article is for informational purposes only and is not a substitute for individualised medical or psychological advice, diagnosis, or treatment. It does not recommend hormone therapy, any medication, or any specific course of treatment, and it is not a substitute for medical evaluation of perimenopausal symptoms. If your sleep problems are persistent or worsening, or if you have symptoms suggesting another sleep disorder, speak with a qualified clinician.